Cytosorbents (CTSO) Treasury Shares (2012 - 2026)
Cytosorbents' (CTSO) quarterly Treasury Shares came in at $2.6 million in Q1 2026, down 5.45% YoY from $2.8 million in Q1 2025, and down 4.3% on a QoQ basis from $2.8 million in Q4 2025.
Cytosorbents (CTSO) Treasury Shares (2012 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 12 years of Treasury Shares data on file, last reported at $2.6 million in Q1 2026.
- Quarterly Treasury Shares fell 5.45% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 5.45% YoY) and the FY2025 annual result came in at $2.8 million, down 1.98% from the prior year.
- Treasury Shares eased to $2.6 million in Q1 2026, from $2.8 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.8 million in Q4 2024 to a low of $125340.0 in Q2 2022.
- A 5-year average of $979605.2 and a median of $460505.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares tumbled 63.59% — and 2024, when it jumped 552.61%.
- Tracing CTSO's Treasury Shares over 5 years: stood at $312092.0 in 2022, then jumped by 37.94% to $430505.0 in 2023, then jumped by 552.61% to $2.8 million in 2024, then dropped by 1.98% to $2.8 million in 2025, then dropped by 4.3% to $2.6 million in 2026.
- The last three Treasury Shares figures came in at $2.6 million (Q1 2026), $2.8 million (Q4 2025), and $810300.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.92 Bn | 196.32 Bn | 7.27 Bn | 267.91 Mn |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.03 Bn | 109.81 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.38 Bn | 73.84 Bn | 3.85 Bn | 303.21 Mn |
| 5 | Edwards Lifesciences | 51.74 Bn | 47.49 Bn | 1.35 Bn | 85.10 Mn |
| 6 | Dexcom | 35.06 Bn | 33.11 Bn | 830.00 Mn | 2.73 Bn |
| 7 | GE HealthCare Technologies | 33.81 Bn | 31.70 Bn | 2.18 Bn | 525.00 Mn |
| 8 | Koninklijke Philips | 26.25 Bn | 22.93 Bn | 4.55 Bn | 16.27 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | - |
| 10 | Cytosorbents | 22.65 Mn | 18.24 Mn | 7.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.64 Mn |
| Jun 30, 2026 | 2.64 Mn |
| Mar 31, 2026 | 2.64 Mn |
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 810,300.00 |
| Sep 30, 2025 | 810,300.00 |
| Jun 30, 2025 | 547,335.00 |
| Jun 30, 2025 | 547,335.00 |
| Mar 31, 2025 | 2.79 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Sep 30, 2024 | 641,336.00 |
| Sep 30, 2024 | 641,336.00 |
| Jun 30, 2024 | 743,505.00 |
| Jun 30, 2024 | 743,505.00 |
| Mar 31, 2024 | 460,505.00 |
| Mar 31, 2024 | 460,505.00 |